"Sanford Medical Center Fargo, North Dakotas newest and largest medical center, serves as a regional health care hub with 60 percent of patients coming from outside the metro area. It is also the regions largest and busiest adult trauma center and pediatric trauma center supported by AirMed transport services covering a three-state area."

During the past decade, Sanford Medical Center-Fargo conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 58 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 29 clinical trials were completed. i.e. 58% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Medical Center-Fargo" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "Sanford Health" with 10 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Medical Center-Fargo" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "University of North Dakota" with 3 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Medical Center-Fargo" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Breast Cancer" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials) and "Stage IVB Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Sanford Medical Center-Fargo" in a lesser frequency.

Most popular intervention types in "Sanford Medical Center-Fargo" are "Drug" (94 trials), "Other" (53 trials), "Biological" (42 trials), "Procedure" (23 trials) and "Device" (16 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Questionnaire Administration" (12 trials), "Carboplatin" (10 trials), "Paclitaxel" (10 trials) and "Biospecimen Collection" (9 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Medical Center-Fargo" are 122 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Sanford Medical Center-Fargo". undefined are not yet recruiting, 43 are recruiting, 32 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in Sanford Medical Center-Fargo, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Medical Center-Fargo, 2 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".